CION Cancer Clinics
HCC statistics and how to read them without being misled | CION Cancer Clinics
HCC survival statistics describe large groups of people diagnosed years ago, not you or your parent. They mix early and late cancers, healthy and failing livers, and treatments that have since changed. This page explains what the common figures measure, why they mislead when applied to one person, and which questions to take to the oncologist who knows the scans and the liver. At CION Cancer Clinics in Hyderabad, our oncologists explain liver cancer in plain words and plan care around you and your family.
On this page
- What do HCC survival statistics actually tell me?
- Why might an HCC statistic I found online be wrong for my family?
- How do I read an HCC statistic without being misled?
- What do the words in survival statistics mean?
- What do families often get wrong about HCC numbers?
- What this page cannot tell you
- Common questions about HCC statistics
The short answer
What do HCC survival statistics actually tell me?
HCC statistics describe what happened to large groups of people, diagnosed several years ago, at every stage and with every kind of liver. They cannot tell you what will happen to you or your parent. They are useful for planning health services and for comparing treatments, and much less useful for predicting one life.
This page is about primary liver cancer
HCC, or hepatocellular carcinoma, is cancer that starts in the liver's own cells. If the cancer started in the bowel, breast or pancreas and spread to the liver, the figures for HCC do not apply at all. That reader needs the statistics for the original cancer, and our page on secondary liver cancer explains why.
Why HCC numbers are harder to read than most
In most cancers, the figures follow the tumour. In HCC they follow two illnesses at once: the cancer and the liver it grew in. Many people with HCC also have cirrhosis, which means long-term scarring of the liver. How well that liver works can shape the outlook as much as the tumour. A statistic that ignores the liver leaves out half the story.
A number about a group is not a forecast about a person.Where the numbers mislead
Why might an HCC statistic I found online be wrong for my family?
The figure itself is usually accurate. The trouble is who it was measured on, and when.
It mixes every stage together
An overall figure blends people found early on a surveillance scan with people diagnosed only when they were already very unwell. The average describes neither group well.
It ignores the liver
Two people with the same tumour can have very different livers. One may cope with surgery or ablation. The other may not cope with any cancer treatment at all. Most published figures do not separate them.
It is old by the time you read it
Long-term figures need years of follow-up, so they describe people treated before today's medicines existed. Immunotherapy combinations and newer targeted drugs have changed advanced HCC care since then.
It comes from somewhere else
Most published figures come from the United States, Europe or East Asia. The causes of HCC, how early it is found and access to treatment differ in Telangana and Andhra Pradesh.
Ask instead
- Which stage was this figure for?
- Did it include people with cirrhosis?
- Which years were these people treated in?
Not sure whether this applies to you?
Ask an oncologistA simple method
How do I read an HCC statistic without being misled?
Find out what is being counted
Is it everyone alive at a certain point, or only people who did not die of the cancer? Is it the middle point of a group, or an average? These give very different numbers from the same patients.
Check the stage and the liver
Look for the BCLC stage, the system liver doctors use, and the Child-Pugh grade, a score of how well the liver works. Our page on why liver cancer uses BCLC explains both. A figure without them is close to meaningless for one person.
Check the dates
Ask when the people in the figure were diagnosed. If it was before modern combination treatment, the figure may understate what is possible now for advanced disease.
Check the treatment
A figure from people who had surgery or a transplant cannot be applied to someone who was not suitable for either, and the reverse is also true.
Take the question to the treating team
Your oncologist knows the tumour, the liver and the person. They can say what the figures mean for your situation, and when the evidence is simply thin.
On the page you read
What do the words in survival statistics mean?
- Five-year survival
- The share of people still alive five years after diagnosis. It says nothing about how they were feeling or whether the cancer was still there.
- Relative survival
- Survival compared with people of the same age and sex who do not have cancer. It tries to strip out deaths from other causes.
- Median survival
- The point at which half the group is still alive. Half of the people live longer than this, sometimes much longer. It is not a deadline.
- Localised, regional, distant
- Groupings used by some cancer registries: in the liver only, spread to nearby structures, or spread to distant organs. They do not account for liver function.
- Hazard ratio
- A trial term comparing two treatments. It shows which did better on average, not how long anyone lived.
- Lead-time bias
- When a cancer is found earlier, the clock starts earlier. Survival can look longer even if the date of death would not have changed.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What do families often get wrong about HCC numbers?
Overall figures for HCC look grim because so many people are found late. A small tumour found on surveillance in a liver that still works well is often curable with surgery, ablation or a transplant. The overall figure hides that group completely.
A median is the middle of a group, not a date for a person. Half the people in that group lived longer, and some lived far longer. No figure can say which half your father is in.
Trials enrol people with fairly healthy livers and good general fitness. If your parent's liver is weaker, the trial figure may not apply. How the medicines work is covered on our page on immunotherapy for HCC.
Some people want figures and some do not, and both are reasonable. You can tell your doctor how much you want to hear, and change your mind later.
Surveillance scans for people with cirrhosis or hepatitis B exist because HCC found early is far more treatable than HCC found late. That one difference moves outcomes more than almost anything else in the statistics. Our page on surveillance for hepatitis B carriers explains who qualifies.
Being straight with you
What this page cannot tell you
It cannot tell you how long you or someone you love will live. No website can, and neither can any single figure. The people best placed to discuss outlook are the oncologist and the hepatologist who have seen the scans, the blood tests and the person in front of them.
It deliberately gives no figures
We have not printed survival percentages or months on this page. A figure placed beside a decision can push a family towards or away from a treatment for the wrong reason. If you want figures, ask the treating team for the ones that fit your stage, your liver and the treatment on offer.
Who this does not apply to
This page is not for cancer that spread to the liver from elsewhere, for bile duct cancer inside the liver, or for children with liver tumours, whose outlook follows different rules. Hepatoblastoma in children is covered on our childhood liver cancer page.
At CION, every liver cancer plan is reviewed by a tumour board. You can ask that team to explain what the evidence says for your situation.Questions we are asked
Common questions about HCC statistics
Is HCC always fatal?
No. A small HCC found early, in a liver that still works well, is often treated with curative intent through surgery, ablation or a transplant. Advanced HCC is harder to treat, but modern medicines can control it for a while in some people. Your treating team can explain which situation applies to you.
Why do different websites give such different numbers?
They measure different groups, in different countries and in different years. Some count everyone, some only one stage. Some count all deaths, some only cancer deaths. None of them is necessarily wrong. They are answering different questions from the one you are asking.
Should I ask my doctor for a survival figure?
You can, and a good doctor will answer honestly. It helps to ask what the figure is based on and how it fits your stage and liver function. You can also say you would rather not hear numbers. Both choices are respected.
Does cirrhosis make the statistics worse?
Cirrhosis affects which treatments are safe, and a weak liver can shape the outlook as much as the tumour. That is why doctors look at the Child-Pugh grade alongside the stage. A person with stable cirrhosis may have far more options than one whose liver is failing.
Are Indian statistics for HCC different?
Indian data for HCC is limited, and much of it comes from single hospitals rather than population registries. Late diagnosis is common here, which pulls overall figures down. That is a reason to take surveillance seriously, not a prediction about any one person.
Can statistics change after treatment starts?
Yes. How the tumour responds, and how the liver copes, changes the picture. A figure from the day of diagnosis is less relevant once you know how treatment is going. Restaging scans help the team update the plan, and our page on being restaged explains this.
What if the cancer spread to the liver from elsewhere?
Then it is secondary liver cancer, and HCC statistics do not apply. The outlook follows the original cancer, such as bowel or breast cancer. Ask your doctor where the cancer started, because it changes almost everything about treatment and what the numbers mean.
Who can explain my parent's outlook properly?
The oncologist who has reviewed the scans, the blood tests and the person's fitness. At CION, the tumour board looks at the tumour and the liver together. Call the helpline if you want a consultation or a second opinion on an existing plan.
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Liver Cancer Survival Rates
- Cancer Research UK — Survival for liver cancer
- American Cancer Society — Liver Cancer Stages
- EASL — EASL Clinical Practice Guidelines: management of hepatocellular carcinoma
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Want someone to explain what the numbers mean for you?
Our oncologists can review the scans, blood tests and liver function, and explain honestly what the evidence says for your situation. One helpline serves every CION centre.